New research claims that the minimally invasive MRI-guided transurethral ultrasound ablation (Tulsa) treatment effectively treats prostate cancer with minimal side effects. The Tulsa method is designed to deliver precise doses of sound waves to diseased prostate tissue while sparing the healthy nerve tissue that surrounds the prostate. The method rivals current techniques that lack sophisticated […]
Eko raises $20m Series B for smart cardiac monitor | Funding Roundup, September 26, 2019
Eko said yesterday that it raised a $20 million Series B round for the smart cardiac monitor it’s developing. The San Francisco-based company is working on machine learning technology for a combined digital stethoscope and electrocardiogram, designed for both clinical and at-home monitoring. Eko said more than 3,000 hospitals worldwide use its platform, treating millions […]
Profound Medical inks $8m private placement deal
Profound Medical (TSX:PRN) last week grossed nearly $8 million from a private placement with a pair of investment banks. Mississauga, Ontario-based Profound, which developed the Tulsa-Pro MR-guided prostate ablation device, said it sold a total of 9.1 million units at 83¢ (C$1.10) apiece to Canaccord Genuity and Echelon Wealth Partners for gross proceeds of about $7.5 […]
Google taps ex-Geisinger CEO Feinberg to lead consolidated Google Health biz | Personnel Moves – November 14, 2018
Google (NSDQ:GOOG) has picked up former Geisinger Health CEO David Feinberg to lead its fragmented health divisions under the Google Health moniker, according to a recent CNBC report. The tech giant had been searching for a head for several months, with artificial intelligence head Jeff Dean heavily involved in the process, according to the report. Other […]
Medin Technologies taps Donaldson as CEO | Personnel Moves – April 25, 2017
Medin Technologies said last week it tapped Bill Donaldson as its new chief executive officer, replacing Andy Novotny who is resigning from his position at the head of the company. Prior to joining Medin Technologies, Donaldson served as president of Jeld-Wen Canada, leading the business unit during its parent company’s initial public offering, Totowa, N.J.-based […]
Profound Medical closes $35m “bought deal” funding round to support pivotal study
Profound Medical (TSX:PRN) said today it closed a”bought deal” financing round raising a total of $34.5 million in gross proceeds with funds slated to support the company’s Tact pivotal trial. In the deal, which was announced in late February, the Mississauga, Ontario-based company said it planned to offer 20 million units at a price of $1 million […]
Profound Medical prices $20m bought deal financing round
Profound Medical (TSX:PRN) yesterday announced an upcoming $20 million “bought deal” financing round. In the deal, the Mississauga, Ontario-based company said it will offer 20 million units at a price of $1 million per unit, for gross proceeds of $20 million. Each unit in the round will consist of a single common share and one-half of a […]
Profound Medical raises $8m for urology, women’s health devices
Profound Medical (TSX:PRN) said today that it inked an $8 million “bought” deal” financing with a pair of underwriters that it plans to use for its Tulsa-Pro and Sonalleve ablation devices. The funding, by Echelon Wealth Partners and CIBC Capital Markets, involved 10 million units at 80¢ (C$1 ) apiece, consisting of a stock share and […]
Profound Medical closes $6m Philips Sonalleve MR-HIFU biz buy
Profound Medical (TSX:PRN) said today it closed its $6 million acquisition of Royal Philips (NYSE:PHG) Sonalleve MR-HIFU business. Philips Sonalleve MR-HIFU platform features real-time MR imaging and thermometry alongside high intensity focused ultrasound for incision-free ablation of tissue, Toronto-based Profound Medical said. “This transaction with Philips is truly transformative for Profound, and represents an opportunity for us […]
Profound Medical to pay $6m for Philips’ Sonalleve MR-HIFU biz
Profound Medical (TSX:PRN) said today that it agreed to put up about $6 million worth of its own shares to acquire the Sonalleve MR-HIFU business from Royal Philips (NYSE:PHG). Toronto-based Profound said the deal calls for it to put up 7.4 million shares at 84.9¢ (C$1.10) apiece, representing a 22% premium over its closing price yesterday. The […]
Profound Medical looks to raise $15m
Profound Medical (TSX:PRN) said today that it pulled in a $13.2 million (C$17.4 million) funding round that includes an over-allotment option that could bring in another $2 million (C$2.6 million). Led by GMP Securities, the syndicate of underwriters agreed to buy 15.82 million shares at about 84¢ (C$1.10) apiece, with an optional over-allotment of 2.373 million shares for the 30 […]
